🇺🇸 ZA in United States

78 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 78

Most-reported reactions

1. Nausea — 11 reports (14.1%)
2. Infusion Related Reaction — 10 reports (12.82%)
3. Haemoglobin Decreased — 9 reports (11.54%)
4. Back Pain — 8 reports (10.26%)
5. White Blood Cell Count Decreased — 8 reports (10.26%)
6. Blood Pressure Increased — 7 reports (8.97%)
7. Neutropenia — 7 reports (8.97%)
8. Arthralgia — 6 reports (7.69%)
9. Malignant Neoplasm Progression — 6 reports (7.69%)
10. Neoplasm Progression — 6 reports (7.69%)

Source database →

Frequently asked questions

Is ZA approved in United States?

ZA does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for ZA in United States?

Merck Sharp & Dohme LLC is the originator. The local marketing authorisation holder may differ — check the official source linked above.